<unk>  is a human blood<unk>  factor that is FDA approved for the treatment of bleeding episodes and peri-operative management in adults and children with hemophilia A or B with inhibitors, congenital Factor VII (FVII) deficiency, and Glanzmann’s thrombasthenia with refractoriness to platelet transfusions, with or without antibodies to platelets, bleeding episodes and peri-operative management in adults with acquired hemophilia. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include hypertension, fever.
Coagulation factor VIIa
Coagulation factor IX
Antithrombin III
Factor IX complex
Thrombus precursor protein 
Coagulation factor XIII A-subunit
Factor ix complex
Plasminogen